LB Pharmaceuticals (LBRX) Stock News
$LBRX · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on LB Pharmaceuticals (LBRX) in the past 30 days. BORSA’s news read on LBRX is balanced at 50/100, unchanged over 24 hours, based on 1 company event over the past 7 days. LB Pharmaceuticals’ next earnings report is scheduled for Thursday, Nov 5.
The wire on $LBRX
newest first · updated · direct subject stories onlyLB Pharmaceuticals Grants Inducement Options to New CMO and CFO
LB Pharmaceuticals granted inducement stock options to its new Chief Medical Officer and Chief Financial Officer. Each received options for 200,000 shares at $37.22, vesting over four years. The grants are standard equity awards to attract senior executives.
neutral 50 · impact 10